CAS: 154-82-5; 2-(2-Methoxy-4-Propylphenoxy)-1-[4-[2-(2-Methoxy-4-Propylphenoxy)Acetyl]Piperazin-1-Yl]Ethanone

该化合物是一种专门的有机化合物,其核心为管子子子,有两种[2-methoxy-4-丙基苯氧基]乙基)替代成分,具有独特的物理化学特性,适合医药中间体或农用化学研究的应用; 甲氧基和丙基基基组的存在可增强脂性,有可能改善目标系统中的生物利用率或基底相互作用; 其对称设计可确保持续再活动,而管子脊柱骨则为进一步衍生提供多功能; 化合物在标准条件下的稳定性有利于处理和储存; 研究人员可探索其在药物发现或物质科学中的效用,因为其分子重量和功能组相容.

结构式图片

MSDS等安全信息

    合成工艺路线路线简述

      海关参考信息

      专利信息


      专利号:US-2024287041-A1
      优先权日:2021-05-20
      标题 :Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms
      发明人:BALOGLU ERKAN; AUSTAD BRIAN C; ROE DAVID G; KEDUC ANDREW; GOTTSCHLING STEPHEN EDMUND; HECKER EVAN
      权利人:KARYOPHARM THERAPEUTICS INC
      摘要:The present invention relates to a method of preparing a compound represented by structural formula (VII), comprising reacting a compound represented by structural formula (II), with a compound represented by structural formula (III), in a solvent, in the presence of a Pd catalyst and one or more inorganic bases under conditions suitable to prepare a compound represented by structural formula (VII): The values and example values of the variables in structural formulas (VII), (II), and (III) are defined herein. The present invention also relates to crystalline Forms I and II of the compound represented by Structural Formula (VII), the use of the crystalline Forms in treating disease or disorders associated with CRM1 and method of preparing the crystalline Forms.

      专利号:AU-2022276509-A1
      优先权日:2021-05-20
      标题:Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms

      专利号:US-9994558-B2
      优先权日:2013-09-20
      标题 :Multicyclic compounds and methods of using same
      发明人:BALOGLU ERKAN; SHACHAM SHARON; SENAPEDIS WILLIAM; MCCAULEY DILARA; LANDESMAN YOSEF; GOLAN GALI; KALID ORI; SHECHTER SHARON
      权利人:KARYOPHARM THERAPEUTICS INC
      摘要:The invention generally relates to compounds represented by Structural Formula I: or a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of structural formula I, or a pharmaceutically acceptable salt or composition thereof, e.g., in treatment of cancer (e.g., mantle cell lymphoma), and other diseases and disorders (e.g., PAK-mediated, for example, PAK4-mediated, diseases and disorders).

      专利号:WO-2022246227-A1
      优先权日:2021-05-20
      标 题:Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms

      专利号:US-10363247-B2
      优先权日:2015-08-18
      标 题:(S,E)-3-(6-aminopyridin-3-yl)-N-((5-(4-(3-fluoro-3-methylpyrrolidine-1-carbonyl)phenyl-7-(4-fluorophenyl)benzofuran-2-yl)methyl)acrylamide for the treatment of cancer
      发明人:BALOGLU ERKAN; SHACHAM SHARON; SENAPEDIS WILLIAM
      权利人:KARYOPHARM THERAPEUTICS INC
      摘要:The invention generally relates to substituted benzofuranyl compounds and, more particularly, to a compound represented by Structural Formula 1a: (I) or a pharmaceutically acceptable salt thereof. The invention also includes the synthesis and use of the compound of Structural Formula 1a, or a pharmaceutically acceptable salt or composition thereof, e.g., in the treatment of diseases or disorder selected from cancer (e.g., lymphoma, such as mantle cell lymphoma), a neurodegenerative disease, an inflammatory diseases or an immune system disease (e.g., a T-Cell mediated autoimmune disease) in a subject in need thereof. The method comprises administering to a subject in need thereof a therapeutically effective amount of a compound of the invention, or a pharmaceutically acceptable salt thereof, or a composition comprising a compound of the invention, or a pharmaceutically acceptable salt thereof.

      专利号:CA-3219525-A1
      优先权日:2021-05-20
      标 题:Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms
      千辉药业(安徽)有限责任公司
      ⚠️ 未注册 · 未认证企业
      ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
      数据来源于公开网络搜索,平台未作核实,请自行辨别。
      🏢敬请 企业认领
      🏬开设公司展台
      📢获取免费会员权益
      🎖️点亮专属注册企业标签
      📇展现公司完整信息 样本查看立即注册认领 →
      网址: http://www.cheerfine.com
      企业联系电话:0551-63872698;13956978892👤
      📞千辉药业(安徽)有限责任公司 ⚠️参考联系方式
      联系人:张经理
      电话:0551-63872698;13956978892

      传真:0551-63872699
      邮箱:info@cheerfine.com
      通信地址: 安徽省合肥市经济技术开发区汤口路2066号
      邮编: 230601
      🆔 联系时候可告知是从"百琢研"平台获取的信息.
      ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

      地址:安徽省合肥市经济技术开发区汤口路2066号
      ⚠️ 未注册 · 未认证企业
      注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
      ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
      第 1 / 1 页
      现货

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      主要参考文献


      1: Yu P, Ma Z, Jiang H, Liu J, Li H. Sinapine thiocyanate alleviates intervertebral disc degeneration by not regulating JAK1/STAT3/NLRP3 signal pathway. Adv Clin Exp Med. 2024 Feb 13. doi: 10.17219/acem/174508. Epub ahead of print.
      236:115726. doi: 10.1016/j.jpba.2023.115726. Epub 2023 Sep 17. 24(1):2249170. doi: 10.1080/15384047.2023.2249170.
      4: Zhao SM, Gong XY, Hu J, DI K, Shan JJ, Wang HS, Zhang C, Liu LY. [Anti-asthma components and mechanism of Kechuanting acupoint application therapy: based on serum metabolomics and network pharmacology]. Zhongguo Zhong Yao Za Zhi. 2022 Dec;47(24):6780-6793. Chinese. doi: 10.19540/j.cnki.cjcmm.20220614.501.

      合成参考文献


      摘要:Modern Pharmaceuticals of Japan, III, Tokyo, Japan Pharmaceutical, Medical and Dental Suppl Exporters' Assoc., 1968, -(84), 1968
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知